Back to News
Market Impact: 0.5

JMP maintains Market Perform rating on LegalZoom stock amid competitive pressures

LZUBS
Company FundamentalsCorporate EarningsAnalyst InsightsAnalyst EstimatesArtificial IntelligencePatents & Intellectual PropertyMarket Technicals & FlowsProduct Launches
JMP maintains Market Perform rating on LegalZoom stock amid competitive pressures

LegalZoom (LZ) reported Q2 2025 revenue exceeding forecasts and accelerating subscription unit growth to 22%, though its stock declined aftermarket. Analyst sentiment is mixed, with BofA upgrading LZ to Buy and raising its price target to $12, citing successful shifts to subscription models and AI collaborations. Conversely, JMP Securities reiterated its Market Perform rating, acknowledging strong brand and near-term fundamentals but expressing concern over competitive intensity and awaiting sustained high-end growth evidence, while UBS maintained a Neutral rating despite raising its price target to $12.

Analysis

LegalZoom.com (LZ) presents a dichotomous profile of strong fundamental performance against a backdrop of competitive pressure and mixed analyst sentiment. The company reported robust second-quarter 2025 results, with revenue of $192.5 million surpassing forecasts by 5.35% and earnings per share meeting expectations at $0.15. This financial strength is underpinned by impressive 66% gross profit margins and a successful strategic pivot towards subscription-based services, evidenced by a significant 22% acceleration in subscription unit growth during the quarter. This transition has earned a stock upgrade from BofA Securities to 'Buy' with a price target increase to $12.00, citing the subscription shift and AI collaborations. However, JMP Securities reiterated its 'Market Perform' rating, acknowledging LegalZoom's dominant brand awareness—five times greater than any competitor—but expressing caution over 'persistent competitive intensity' as the company moves away from its freemium model. JMP awaits further evidence of sustained growth at the higher end of the market. This cautious sentiment is echoed by UBS, which maintains a 'Neutral' rating despite raising its price target to $12.00. The stock's decline in aftermarket trading, despite the positive earnings report, suggests investor uncertainty about whether the company's product differentiation can justify its premium pricing in a crowded market.

AllMind AI Terminal